市場調查報告書
商品編碼
1351007
全球骨科生物材料市場 2023-2030Global Orthopedic Biomaterials Market 2023-2030 |
預計全球骨科生物材料市場在預測期內將以 7.2% 的年複合成長率成長。市場的成長歸因於骨科疾病日益流行、骨科手術數量增加、技術進步以及老年人口不斷成長等因素。此外,對微創手術的需求、機器人輔助手術的採用以及先進骨科生物材料的可用性等因素預計將推動骨科生物材料市場的需求。
全球骨科生物材料市場的成長主要是由政府機構以及非政府機構為大學開發各種新型生物材料增加資金和補助金所推動的。例如,2018年3月,德雷塞爾大學向美國國家科學基金會撥款總計20萬美元。這筆補助用於促進生物材料介導的巨噬細胞行為控制如何影響生物材料血管化的研究。此外,植入式設備需求的增加和再生醫學研究的增加等因素進一步推動了市場的成長。然而,嚴格的臨床和監管流程以及不利的醫療改革可能會對骨科生物材料市場的成長構成挑戰。
Title: Global Orthopedic biomaterial Market Size, Share & Trends Analysis Report, By Material Type (Polymers, Ceramics & Bioactive Glasses, Calcium Phosphate Cements, Metal, Others), By Application (Orthobiologics, Joint Replacement/Reconstruction, Viscosupplementation, Orthopedic Implants, Others) Forecast Period (2022-2030).
The global orthopedic biomaterial market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period. The growth of the market is attributed to factors such as the increasing prevalence of orthopedic conditions, a rise in the number of orthopedic surgeries, advancements in technology, and the growing geriatric population. Further, factors such as the demand for minimally invasive procedures, the adoption of robotic-assisted surgeries, and the availability of advanced orthopedic biomaterial are expected to fuel the demand for orthopedic biomaterial market.
The growth of the global orthopedic biomaterial market is mainly driven by increased funds and grants by government bodies as well as non-government bodies to the universities for the development of various new novel biomaterials. For instance, In March 2018, Drexel University granted a total of $200,000 to the National Science Foundation. This grant is provided for promoting the research on how biomaterial-mediated control over macrophage behavior affects biomaterial vascularization. Additionally, factors such as increasing demand for implantable devices and increasing research on regenerative medicine further give a boost to the growth of the market. However, stringent clinical & regulatory processes and unfavorable healthcare reforms may present as a challenge for the orthopedic biomaterial market growth.
The global orthopedic biomaterial market is segmented based on material type and application. Based on material type, the market is segmented into polymers, ceramics & bioactive glasses, calcium phosphate cements, metal, and others. Based on application, the market is sub-segmented into Orthobiologics, joint replacement/reconstruction, viscosupplementation, orthopedic implants, and others.
The ceramics & bioactive glasses segment by material type is projected to exhibit fastest growth during the forecast period. The increasing adoption of several spine surgeries and interbody fusion procedures are contributing to the growth of this market segment. In addition, an increase in synthetic cages and pedicle screws during fixation procedures drives segment growth. Synthetic cages and pedicle screws maintain stability in the target patient pool and increase allograft fusion rates; which is further contributing to the market growth.
The global orthopedic biomaterial market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Among these, the Asia-Pacific market is anticipated to cater to a considerable growth over the forecast period. Asia-Pacific is anticipated to exhibit a considerable growth rate in the orthopedic biomaterial market due to the increasing geriatric population coupled with the increased cases of fracture and surgery. India and China are the major economies in Asia-Pacific and the market of biomaterial will grow significantly in these regions. Additionally, the presence of various research institutes in the region and investments would boost the orthopedic biomaterial market in the Asia-Pacific. Further, the region is adopting strategic initiatives to reinforce its presence in local as well as global markets. For instance, in November 2019, a Japan-based company, Mitsubishi Chemical signed an agreement with the US-based AdvanSource Biomaterials for acquiring their thermoplastic polyurethane elastomer business. This acquisition is expected to the company to expand its business footprint globally and capture significant share in the international market.
North America held a considerable share in the global orthopedic biomaterial market. In North America, the US held a major market share. Owing to the increasing cases of orthopedic surgeries, the market of biomaterial will grow significantly in the region. Additionally, the well-established healthcare sector of the US coupled with government support will also aid in the orthopedic biomaterial market shares. Along with North America, Europe also has good potential for the growth of the biomaterial market in the region. The growth of the biomaterial market in Europe is associated with the increasing demand in the medical sector to use mostly natural and environmentally friendly products.
The major companies serving the global orthopedic biomaterial market include among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Synergy Biomedical, LLC, a developer of innovative biomaterial products, launched BIOSPHERE FLEX SP EXTREMITIES, Synthetic Bioactive Bone Graft. Using Synergy's proprietary BIOSPHERE Technology, BIOSPHERE FLEX SP Extremities is a sheet putty composed of innovative spherical bioactive glass granules combined with a porous collagen/sodium hyaluronate carrier. This product addition adds to the already highly successful Synergy FLEX sheet putty product portfolio. Flex SP Extremities expects to be an integral solution into the Upper and Lower Extremity market.